Takeshi Takahashi
Direktor/Vorstandsmitglied bei Pathalys Pharma, Inc.
Aktive Positionen von Takeshi Takahashi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Takeshi Takahashi
Ehemalige bekannte Positionen von Takeshi Takahashi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2020 | 12.09.2023 |
| Independent Dir/Board Member | 01.05.2020 | 12.09.2023 | |
| TSUGAMI CORPORATION | Geschäftsführer | 01.04.2020 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 | - | |
| Corporate Officer/Principal | - | 01.04.2020 |
Ausbildung von Takeshi Takahashi
| Waseda University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Japan | 3 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| TSUGAMI CORPORATION | Producer Manufacturing |
| Private Unternehmen | 1 |
|---|---|
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Health Technology |
- Börse
- Insiders
- Takeshi Takahashi
- Erfahrung
